Ex vivo drug testing on fresh tumor tissue to help predict whether a treatment will work before it is given.
Consented intake · your records travel with you · nothing moves without your sign-off
Xilis performs functional testing: drugs are applied to a patient's fresh tumor tissue and the response is observed directly. Turnaround ranges from two days to six weeks, and obtaining fresh tissue can be a limitation to plan around. The value for patients is greater confidence that a chosen drug or combination will actually produce a response.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Xilis handles billing.
We don't have confirmed insurance details for Xilis yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Xilis's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.